{"denomUnitsSelected":"Participants","description":"Will evaluate other biomarkers as predictors of response to tazemetostat and specifically, whether tumors that harbor different missense mutations or fusions will demonstrate differential response to tazemetostat treatment. Will be performed and will be summarized with simple summary statistics and will be descriptive in nature.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 2 years","title":"Biomarker Predictors of Response to Tazemetostat","type":"OTHER_PRE_SPECIFIED"}